Glycoengineering of NK cells with glycan ligands of CD22 and selectins for B-cell lymphoma therapy is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 2P41GM103390-26
Training
National Institutes of Health
Grant: 5P01HL107151-03
Regulated expression of siglec counter-receptors
National Institutes of Health
Grant: 5R01GM111938-05
Chemical tools for studying membrane protein glycosylation
National Institutes of Health
Grant: 5R01GM130915-02
Origin of N-Glycan Site-Specific Heterogeneity
National Institutes of Health
Grant: 5P01GM107012-03
Glycoconjugate Trafficking and Identification in Cells via SEEL
National Institutes of Health
Grant: 1R01GM113046-01A1
Chemoenzymatic methods for the detection of cell-surface glycans
National Institutes of Health
Grant: 6R01GM093282-06
Chemical tools for studying fucosylated glycans
National Institutes of Health
Grant: 5R01AI050143-04
Regulation of Sialoside Expression in Leukocytes
Fields of Study
Keywords
Sustainable Development Goals